✦ LIBER ✦

Pharmacologic characterization of fce 27262, a combined thromboxane synthase inhibitor (TXSI) and TXA2 receptor antagonist (TXRA)

✍ Scribed by SALVATI, P

Book ID: 122833507
Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 92 KB
Volume: 26
Category: Article
ISSN: 1043-6618
DOI: 10.1016/1043-6618(92)91185-J

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Basic pharmacophore of some antithrombot

Basic pharmacophore of some antithrombotic agents with combined thromboxane receptor antagonist (TxRA)/thromboxane synthase inhibitor (TxSI) activity

✍ Yang Jie; Hua Weiyi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB 👁 1 views

Platelet activation, causing formation of platelet aggregates, plays a major role in occlusive thrombus formation which may induce ischemic cardiovascular diseases. Thromboxane A2 (TXA2) is an extremely potent vasoconstricting and platelet-aggregating agent so that it is important to search for a ne

Additive antithrombotic effect of a thro

Additive antithrombotic effect of a thromboxane-synthase inhibitor (TXSI) associated to a fully effective dose of a TXA2-receptor antagonist (TXRA): Comparison with aspirin

✍ P. Salvati; L. Dho; G. Ukmar; L. Vaga; O. Rimoldi; C. Patrono 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Effect of thromboxane A2 (TXA2) synthase

Effect of thromboxane A2 (TXA2) synthase inhibitor and TXA2 receptor antagonist alone and in combination on antigen-induced bronchoconstriction in guinea pigs

✍ Yuzo Yoshimi; Masaki Fujimura; Shigeharu Myou; Hideki Tachibana; Tatsuki Hirose 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 947 KB

Pharmacological Profile and Therapeutic

Pharmacological Profile and Therapeutic Potential of BM-573, a Combined Thromboxane Receptor Antagonist and Synthase Inhibitor

✍ Ghuysen, Alexandre ;Dogné, Jean-Michel ;Chiap, Patrice ;Rolin, Stéphanie ;Masere 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB

Pharmacological evaluation of both enant

Pharmacological evaluation of both enantiomers of (R,S)-BM-591 as thromboxane A2 receptor antagonists and thromboxane synthase inhibitors

✍ S. Rolin; J.M. Dogne; C. Vastersaegher; J. Hanson; B. Masereel 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Pharmacological characterization of EK11

Pharmacological characterization of EK112, a new combined angiotensin II and thromboxane A2 receptor antagonist

✍ Tsong-Long Hwang; Yung-An Yeh; Ji-Wang Chern; Che-Ming Teng 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 220 KB